Eve Damiens

1.7k total citations · 1 hit paper
13 papers, 1.4k citations indexed

About

Eve Damiens is a scholar working on Molecular Biology, Nutrition and Dietetics and Organic Chemistry. According to data from OpenAlex, Eve Damiens has authored 13 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Nutrition and Dietetics and 3 papers in Organic Chemistry. Recurrent topics in Eve Damiens's work include Infant Nutrition and Health (6 papers), RNA Interference and Gene Delivery (3 papers) and Quinazolinone synthesis and applications (3 papers). Eve Damiens is often cited by papers focused on Infant Nutrition and Health (6 papers), RNA Interference and Gene Delivery (3 papers) and Quinazolinone synthesis and applications (3 papers). Eve Damiens collaborates with scholars based in France, Germany and United Kingdom. Eve Damiens's co-authors include Laurent Meijer, Dominique Marie, Gerhard Eisenbrand, Alison M. Lawrie, Ellen Niederberger, Jane Endicott, Doris Marko, Maryse Leost, Sophie Leclerc and Weici Tang and has published in prestigious journals such as Nature Cell Biology, Oncogene and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Eve Damiens

12 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

1999 682 citations Sophie Leclerc, Jane Endicott et al. Nature Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eve Damiens France	9	712	467	268	234	142	13	1.4k
Sankar Mohan Canada	23	842 1.2×	499 1.1×	245 0.9×	360 1.5×	75 0.5×	43	1.9k
C. Martinez-Fleites United Kingdom	18	1.1k 1.5×	423 0.9×	287 1.1×	140 0.6×	182 1.3×	22	1.7k
Wim Nerinckx Belgium	21	1.0k 1.5×	258 0.6×	216 0.8×	72 0.3×	184 1.3×	42	1.8k
Kaori Honda Japan	18	708 1.0×	149 0.3×	70 0.3×	141 0.6×	78 0.5×	47	1.0k
Christopher W. Carreras United States	17	1.1k 1.6×	142 0.3×	91 0.3×	309 1.3×	47 0.3×	35	1.5k
Xingfeng Yin China	23	1.1k 1.5×	112 0.2×	82 0.3×	196 0.8×	104 0.7×	41	1.6k
Rina Das India	19	604 0.8×	245 0.5×	58 0.2×	224 1.0×	99 0.7×	79	1.2k
Steen B. Mortensen Denmark	23	1.1k 1.6×	142 0.3×	51 0.2×	149 0.6×	417 2.9×	32	1.8k
Karen J. Auborn United States	29	1.3k 1.8×	276 0.6×	52 0.2×	406 1.7×	252 1.8×	51	2.3k
Aslamuzzaman Kazi United States	27	1.0k 1.4×	278 0.6×	36 0.1×	513 2.2×	101 0.7×	45	2.1k

Countries citing papers authored by Eve Damiens

Since Specialization

Citations

This map shows the geographic impact of Eve Damiens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eve Damiens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eve Damiens more than expected).

Fields of papers citing papers by Eve Damiens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eve Damiens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eve Damiens. The network helps show where Eve Damiens may publish in the future.

Co-authorship network of co-authors of Eve Damiens

This figure shows the co-authorship network connecting the top 25 collaborators of Eve Damiens. A scholar is included among the top collaborators of Eve Damiens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eve Damiens. Eve Damiens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Damiens, Eve, et al.. (2001). Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest. Oncogene. 20(29). 3786–3797. 116 indexed citations

Loukaci, Ali, et al.. (2001). Coscinosulfate, a CDC25 phosphatase inhibitor from the sponge Coscinoderma mathewsi. Bioorganic & Medicinal Chemistry. 9(11). 3049–3054. 35 indexed citations

Meijer, Laurent, Marie Knockaert, & Eve Damiens. (2001). [Prevention of chemotherapy-induced alopecia by cyclin-dependant kinase inhibitors].. PubMed. 88(4). 347–50. 2 indexed citations

Damiens, Eve. (2000). Molecular events that regulate cell proliferation: an approach for the development of new anticancer drugs. PubMed. 4. 219–233. 9 indexed citations

Knockaert, Marie, Nathanael S. Gray, Eve Damiens, et al.. (2000). Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. Chemistry & Biology. 7(6). 411–422. 189 indexed citations

Dhennin‐Duthille, Isabelle, Maryse Masson, Eve Damiens, et al.. (2000). Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen‐activated protein kinase in the human lymphoblastic T Jurkat cell line. Journal of Cellular Biochemistry. 79(4). 583–593. 1 indexed citations

Damiens, Eve & Laurent Meijer. (2000). [Chemical inhibitors of cyclic-dependent kinases: preclinical and clinical study].. PubMed. 48(3). 340–51. 7 indexed citations

Dhennin‐Duthille, Isabelle, et al.. (2000). Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. Journal of Cellular Biochemistry. 79(4). 583–593. 86 indexed citations

Dhennin‐Duthille, Isabelle, Eve Damiens, M. Masson, et al.. (2000). Comparative studies of human and bovine lactoferrins effects on the immune system.. 129–135. 1 indexed citations

10.

Leclerc, Sophie, Jane Endicott, Alison M. Lawrie, et al.. (1999). Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nature Cell Biology. 1(1). 60–67. 682 indexed citations breakdown →

11.

Damiens, Eve, et al.. (1999). Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. Journal of Cellular Biochemistry. 74(3). 486–498. 122 indexed citations

12.

Damiens, Eve, Ikram El Yazidi‐Belkoura, Joël Mazurier, et al.. (1998). Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line. European Journal of Cell Biology. 77(4). 344–351. 60 indexed citations

13.

Damiens, Eve, Joël Mazurier, Ikram El Yazidi‐Belkoura, et al.. (1998). Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1402(3). 277–287. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact